Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-14-000003

← back to feed
Filed
Feb 11, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jan 14, 2014 111.55M sh
Operating Cash Flow Q2 2014 · Dec 31, 2013 −$35.5K
Operating Cash Flow Q2 2014 · Dec 31, 2013 −$63.85K
Operating Cash Flow Q2 2014 · Dec 31, 2013 −$2.15M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $5K
Cash And Equivalents Q2 2014 · Jun 30, 2013 $7.05K
Stockholders Equity Q2 2014 · Dec 31, 2013 −$2.06M
Stockholders Equity Q2 2014 · Jun 30, 2013 −$2.05M
Total Liabilities Q2 2014 · Dec 31, 2013 $2.07M
Total Liabilities Q2 2014 · Jun 30, 2013 $2.07M
Current Assets Q2 2014 · Dec 31, 2013 $9.58K
Current Assets Q2 2014 · Jun 30, 2013 $12.26K
Net Income Q2 2014 · Dec 31, 2013 −$22.55K
Net Income Q2 2014 · Dec 31, 2013 −$63.33K
Net Income Q2 2014 · Dec 31, 2013 −$2.13M
Operating Income Q2 2014 · Dec 31, 2013 −$22.55K
Operating Income Q2 2014 · Dec 31, 2013 −$63.33K
Operating Income Q2 2014 · Dec 31, 2013 −$2.41M